Mind Medicine (MindMed) Inc.(MNMD), a company focused on psychedelic-inspired therapies, said on Tuesday that Robert Barrow has been named as its new chief executive officer or CEO.
Barrow was serving as as interim CEO of MindMed after J.R. Rahn, resigned as the company's Co-Founder and CEO, earlier this year. Effective immediately, the company has also appointed Carol Vallone as Chair, to replace Perry Dellelce, who previously served as Director and Chairman.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.